[1] Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health[J]. Climacteric,2013,16:316-337. [2] Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progesterone in healthy post- menopausal women[J]. JAMA, 2002,288:321-333. [3] Stefanick ML, Anderson GL, Margolis KL, et al.Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy[J].JAMA, 2006,295:1647-1657. [4] Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone and risk of cardiovascular disease by age and years since menopause[J]. JAMA, 2007,297:1465-1477. [5] Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement[J]. J Clin Endocrinol Metab, 2010,95(7 Suppl 1):s1-s66. [6] Sturdee DW, Pines A,International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health[J]. Climacteric, 2011,14(3):302 320. [7] Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study[J]. Breast Cancer Res Treat, 2008,107(1):103-111. [8] Schierbeck LL, Rejnmark L, Landbo C, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial[J]. BMJ, 2012,345:e6409 doi: 10.1136/bmj.e6409 (Published 9 October 2012). [9] Dinger JC, Heinemann LA. European active surveillance study of women taking HRT (EURAS-HRT): study protocol [NCT00214903][J]. BMC Womens Health,2006,17:1. [10] 中华医学会妇产科学分会绝经学组. 绝经过渡期和绝经后期激素补充治疗临床应用指南(2009版)[J]. 中华妇产科杂志,2010,45(8):635-638. [11] 中华医学会妇产科学分会绝经学组.绝经期管理与激素补充治疗临床应用指南[J].中华妇产科杂志,2013,48(10): [12] North American Menopause Society.The 2012 hormone therapy statement of the north american menopause society[J].Menopause, 2012, 19(3):257-271. [13] Gompel A, Rozenberg S, Barlow DH. EMAS board members:The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy[J]. Maturitas, 2008, 61(3):227-232. [14] Villiers TJ, Gass ML, Haines CJ, et al. Global consensus statement on menopausal hormone therapy[J].Maturitas, 2013,74(4):391-392. |